Omeprazole/Domperidone

奥美拉唑/多潘立酮

Report date: 2022/01/14 13:23:58

Base Information

Drug NameOmeprazole/Domperidone
Drug Alias Name奥美拉唑多潘立酮胶囊
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProton pump inhibitorsDopamine D2 receptor antagonists
TargetsProton pumpDopamine D2 receptor
Therapy Area/IndicationsDyspepsiaStomach UlcerDuodenal Ulcer +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes OmeprazoleDomperidone
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsDyspepsiaStomach UlcerDuodenal Ulcer +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A